1. Home
  2. FLS vs IBRX Comparison

FLS vs IBRX Comparison

Compare FLS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowserve Corporation

FLS

Flowserve Corporation

HOLD

Current Price

$71.06

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.21

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLS
IBRX
Founded
1790
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
7.2B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
FLS
IBRX
Price
$71.06
$8.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
7
Target Price
$86.00
$12.57
AVG Volume (30 Days)
2.0M
12.0M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
1.04%
N/A
EPS Growth
23.36
38.71
EPS
0.64
N/A
Revenue
N/A
$113,288,000.00
Revenue This Year
$6.80
$88.59
Revenue Next Year
$6.22
$131.15
P/E Ratio
$108.89
N/A
Revenue Growth
N/A
668.31
52 Week Low
$48.71
$1.95
52 Week High
$92.41
$12.43

Technical Indicators

Market Signals
Indicator
FLS
IBRX
Relative Strength Index (RSI) 43.69 50.67
Support Level $69.50 $6.69
Resistance Level $73.36 $8.54
Average True Range (ATR) 2.77 0.67
MACD -0.73 0.04
Stochastic Oscillator 22.96 45.31

Price Performance

Historical Comparison
FLS
IBRX

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: